Navigation Links
Chronic Pain Patients Now Have Hope With Carryover Pain Relief Provided By Repeated Interferential Treatments
Date:2/16/2009

The Infrex Plus is now providing chronic pain patients the ability to self treat at home or work on an as needed basis. The surprising development is the amount of "carryover pain relief" most patients are achieving. Now interferential treatments are extending the residual pain relief period and reducing the overall pain levels for chronic pain patients offering better treatment options without the use of opioid drugs.

(PRWEB) February 16, 2009 -- The Infrex Plus is now providing chronic pain patients the ability to self treat at home or work on an as needed basis. The surprising development is the amount of "carryover pain relief" most patients are achieving.

Carryover pain relief, often referred to as "residual pain relief", is nothing more than the time period after the interferential treatment in which the patient has no pain. The phenomenon is not new to interferential for chronic pain patients, but to be able to self-treat as needed is opening new options for the chronic pain patient. " Interferential has been the leading clinical electrotherapy form of pain relief treatment since it's onset in 1951 primarily due to carryover pain relief", but only since November 2008 has the option been affordable and available to the chronic pain patient.

Historically interferential was only available to patients in a clinical setting. The patient would schedule an appointment and then come to the clinic or hospital for the 30 minute interferential treatment. The pain relief was immediate and the patient would leave the facility scheduling a return visit in anticipation of the return of the pain. The patient and clinician guessed how long it would be before the pain returned and the severity of the pain reached the point of needing treatment. In other words the "carryover pain period" was guessed at.

Today with the Infrex Plus the patient can treat as often as necessary whenever the pain returns. The carryover pain relief period is constantly extending from treatment to treatment. This is advancing the treatment of many historically chronic conditions such as:

·   Chronic Back Pain
·   Sciatica
·   Herniated Disc
·   Bulging Disc
·   Spinal Stenosis
·   Lumbar Pain
·   Osteoarthritis
·   Fibromyalgia Syndrome
·   Shingles
·   Phantom Limb Pain
·   Restless Leg Syndrome ( RLS)
·   Cervical Spondylosis
·   Trigeminal Neuralgia
·   Reflex Sympathetic Dystrophy ( RSD)
·   Carpal Tunnel Syndrome ( CTS)

The new interferential/tens Infrex Plus is also reducing the dependency and costs of traditional opioid drugs providing the patient better, safer, and less expensive options.

###

Read the full story at http://www.prweb.com/releases/2009/02/prweb2039394.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. New research shows how chronic stress worsens neurodegenerative disease course
2. Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease
3. Study identifies key player in the bodys immune response to chronic stress
4. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
5. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
6. The Leukemia & Lymphoma Society Hosts Workshop On Weighing Treatment Options For Chronic Myelogenous Leukemia
7. Link Between Chronic Pain and Insomnia Uncovered at PAINWeek 2007
8. Methadone and systematic follow-up: the best solution for managing chronic pain
9. NASN Joins Partnership to Fight Chronic Disease
10. Stomach Virus a Culprit in Chronic Fatigue Syndrome
11. Chronic fatigue syndrome linked to stomach virus
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chronic Pain Patients Now Have Hope With Carryover Pain Relief Provided By Repeated Interferential Treatments 
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: